Latest Regulatory News

Variscan Mines has secured government approval for its Preliminary Mining Plan, enabling critical pre-works and trial mining at the San Jose Mine in Spain. This milestone accelerates the company’s strategy to restart production with minimal capital expenditure.

Anson Resources has secured regulatory approval for a revised drilling approach at its Mt Fuel-Skyline Geyser Well in Utah, overcoming unexpected blockages to advance lithium exploration.

The Star Entertainment Group has reshuffled its leadership, appointing Soo Kim as Chairman and Bruce Mathieson Jnr as CEO, signaling a new strategic phase for the casino giant.

Whitebark Energy’s latest technical review of the Warro Gas Field reveals that water production issues are confined to specific fault zones, enhancing prospects for commercial gas flow and prompting immediate engineering evaluations.

Savannah Goldfields reports steady gold production at its Georgetown plant, with new feedstock from historic sites and a third-party toll treatment agreement supporting continuous operations.

Boab Metals has approved the Final Investment Decision for its Sorby Hills Silver-Lead Project, fully funding construction and targeting first production in the second half of 2027.

Marvel Gold Limited has agreed to sell its Yanfolila Gold Project in Mali to Askiya Mineral Resources for up to US$1.94 million, marking a strategic shift to focus on its Tanzanian assets.

Audalia Resources is set to raise $540,000 through a share placement to fund critical development stages of its Medcalf Project and bolster working capital.

Commonwealth Bank of Australia announces a fully franked quarterly dividend of AUD 1.1326 per security on its PERLS XV capital notes, payable in March 2026.

Commonwealth Bank of Australia announces a fully franked quarterly distribution of AUD 1.1154 per security for its PERLS XIV capital notes, payable in March 2026.

EcoGraf Limited has secured key prospecting licences for its Golden Eagle Project in Tanzania, triggering a $9 million farm-in agreement with global gold giant AngloGold Ashanti. This partnership positions EcoGraf to benefit from exploration upside while focusing on its core graphite business.

Island Pharmaceuticals has inked a Master Service Agreement with Texas Biomedical Research Institute, enhancing its strategic position to advance Galidesivir through the FDA Animal Rule pathway. This partnership aligns with US government priorities on viral threats and sets the stage for a planned clinical program in early 2026.